Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03039P

SDS-PAGE analysis of Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein, CAT# BLT-03039P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03039P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human Putative TGFB1-induced anti-apoptotic factor 1 (TIAF1/MYO18A) Protein |
Product Overview | This recombinant human Putative TGFB1-induced anti-apoptotic factor 1 (TIAF1/MYO18A) protein includes amino acids 1-115aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | O95411 |
Recommended Name | Putative TGFB1-induced anti-apoptotic factor 1 |
Gene Name | MYO18A |
Synonyms | TGFB1-induced anti-apoptotic factor 1, MAJN, SPR210 |
Species | Human |
Predicted Molecular Mass | 16.6 kDa |
Expression System | E.coli |
Expression Range | 1-115aa |
Tag | N-6His |
Purity | >90% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Cell Biology |
Target Function | Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation. |
Subcellular Location | Nucleus. |
Tissue Specificity | Not detectable in normal kidney and liver. Up-regulated in chronic and acute allograft rejection: expressed in the inflammatory infiltrate and in tubular epithelial cells. |